S2Medical AB (S2M) - Total Liabilities

Latest as of June 2025: Skr7.08 Million SEK ≈ $762.14K USD

Based on the latest financial reports, S2Medical AB (S2M) has total liabilities worth Skr7.08 Million SEK (≈ $762.14K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore S2M cash generation efficiency to assess how effectively this company generates cash.

S2Medical AB - Total Liabilities Trend (2015–2025)

This chart illustrates how S2Medical AB's total liabilities have evolved over time, based on quarterly financial data. See shareholders equity of S2Medical AB for net asset value and shareholders' equity analysis.

S2Medical AB Competitors by Total Liabilities

The table below lists competitors of S2Medical AB ranked by their total liabilities.

Company Country Total Liabilities
Ivory Properties Group Bhd
KLSE:5175
Malaysia RM206.09 Million
Oxbridge Re Holdings Equity Warrant
NASDAQ:OXBRW
USA $1.56 Million
Gyldendal A/S
CO:GYLD-B
Denmark Dkr290.27 Million
Panthera Resources PLC
LSE:PAT
UK GBX3.06 Million
EPE Special Opportunities Limited
LSE:ESO
UK GBX15.97 Million
Cora Gold Limited
LSE:CORA
UK GBX282.00K
Panther Securities P L C
LSE:PNS
UK GBX81.31 Million
Ortel Communications Limited
NSE:ORTEL
India Rs4.43 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down S2Medical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see S2Medical AB market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.75 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.38 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.27 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how S2Medical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for S2Medical AB (2015–2025)

The table below shows the annual total liabilities of S2Medical AB from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 Skr6.90 Million
≈ $742.44K
+9.73%
2024-12-31 Skr6.29 Million
≈ $676.58K
-68.17%
2023-12-31 Skr19.75 Million
≈ $2.13 Million
+8.36%
2022-12-31 Skr18.22 Million
≈ $1.96 Million
+21.54%
2021-12-31 Skr15.00 Million
≈ $1.61 Million
+76.90%
2020-12-31 Skr8.48 Million
≈ $912.24K
+51.40%
2019-12-31 Skr5.60 Million
≈ $602.53K
+1.21%
2018-12-31 Skr5.53 Million
≈ $595.34K
+45.66%
2017-12-31 Skr3.80 Million
≈ $408.73K
+3.35%
2016-12-31 Skr3.67 Million
≈ $395.49K
+6.24%
2015-12-31 Skr3.46 Million
≈ $372.24K
--

About S2Medical AB

ST:S2M Sweden Medical Instruments & Supplies
Market Cap
$611.88K
Skr5.69 Million SEK
Market Cap Rank
#30463 Global
#721 in Sweden
Share Price
Skr0.01
Change (1 day)
-5.56%
52-Week Range
Skr0.01 - Skr0.03
All Time High
Skr1000000.00
About

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more